Navigation Links
LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects
Date:1/27/2009

LegalView continued to maintain its newsworthy coverage on its Avandia information portal with the recent addition of several new articles detailing the drug's potentially dangerous side effects. The type 2 diabetes drug has been linked to bone fracture, osteoporosis and heart failure among patients.

Denver, CO (PRWEB) January 27, 2009 -- LegalView.info, the most comprehensive legal site available on the Internet, recently updated its Avandia information portal with new articles providing more detail and insight as to the potential Avandia side effects, which have been shown to range from the onset of osteoporosis to bone fractures among women as well as heart failure risks among all patients. Individuals who have recently consumed the drug and may be at risk for developing one of the drug's side effects should consider speaking with not only their medical professional, but an experienced pharmaceutical attorney as well, who can provide information on a potential Avandia lawsuit.

One of the new articles that can be found on the Avandia information portal details a treatment that can work to relieve one of the Avandia side effects. According to a New England Journal of Medicine article, Avandia patients are at an increased risk of developing heart failure; however, researchers may have discovered a technique in which heart failure victims are revived, and, with little side effects. The technique is that of therapeutic hypothermia and it occurs when a victim is cooled in order to avoid the onset of traumatic brain injury, which is often a side effect of a heart failure incident. Although the treatment offers a potential solution to one of the Avandia risks, it may still be necessary for a patient to receive a free legal consultation from an experienced Avandia lawyer.

In addition to providing continually updated news and information on all things Avandia, LegalView also offers details on a variety of other legal topics including the latest on the Fosamax dangers, the peanut butter recall and the cranial implant kit recall.

Fosamax is an osteoporosis drug from makers Merck and Company. Earlier this month, the drug was deemed dangerous by two separate medical publications for its Fosamax side effects, which include jaw bone die off and the potential onset of esophageal cancer. Patients who currently take the drug for bone density loss or osteoporosis should consider seeking medical attention immediately as it may be necessary to stop consumption of the drug.

LegalView has also been providing up-to-the minute news on the peanut butter recall, which has caused nearly 500 U.S. citizens to contract salmonella, seven of which have become fatal, according to multiple news reports. To learn more about the peanut butter recall, individuals are encouraged to obtain information at http://peanut-butter.legalview.info/.
One of the most potentially serious recalls to occur this year is that of Stryker Corporation's Custom Cranial Implant Kit recalls, which were recalled due to issues surrounding the sterility of the kits. If not surgically removed, a patient faces the potential for developing serious side effects as well as an increased risk of death. Patients who have received one of the 322 recalled cranial implant kits should speak with their surgeon immediately to determine the safest way to have the kits removed. Additionally, because of the severity of the side effects and the costs associated with having the kits recalled, it may be advisable for a patient to discuss the development of a cranial implant lawsuit with their attorney, as monetary compensation could be an outcome of such litigation.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.info.

###

Read the full story at http://www.prweb.com/releases/2009/01/prweb1915954.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
Breaking Medicine Technology: